Insights Into Prostate Cancer
Perspectives on drivers in treatment decisions in the management of prostate cancer
Faculty Chair
Mehmet Asim Bilen, MD
Winship Cancer Institute, Atlanta, GA, USA
Faculty Chair
Rana McKay, MD
University of California San Diego Medical Center, San Diego, CA, USA
Faculty Chair
Russell Szmulewitz, MD
UChicago Medicine, Chicago, IL, USA
Faculty Chair
Atish Choudhury, MD, PhD
Dana-Farber Cancer Institute, Boston, MA, USA
Faculty Chair
Terence Friedlander, MD
UCSF Health, Francisco, CA, USA
More Information
- Atlanta, GA
- Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia
More Information
- Virtual series
- Southern California, Nevada, Utah, Arizona, New Mexico, Colorado
More Information
- Dallas, TX
- Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana
More Information
- Chicago, IL
- Illinois, Iowa, Minnesota, Nebraska, North Dakota, South Dakota, Wisconsin, Michigan, Indiana, Ohio
More Information
- Philadelphia, PA
- Connecticut, Delaware, District of Columbia, Maine, Massachusetts, Maryland, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont
More Information
- Seattle, WA
- Northern California, Oregon, Washington, Idaho, Montana, Wyoming
REPORT SNAPSHOT
- A moderated roundtable discussion focusing on the treatment of prostate cancer
- Disease state and data presentations are developed in conjunction with a national or regional oncology expert
- Insights on the following therapies will be obtained: apalutamide, darolutamide, enzalutamide, androgen deprivation therapy, docetaxel, abiraterone, and combinations of these drugs
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection is accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprises 10–15 medical oncologists representative of each region